'Post-Covid complications a new dimension, have to be aware'

PostCovid complications like respiratory symptoms and an immunological response in children are a new dimension and people have to be aware of them a top official dealing with the pandemic said on TuesdayThe caution comes as Union Home Minister Amit Shah was admitted to the All India Institute of Medical Sciences here on Tuesday after he complained of fatigue and body ache four days after he tested negative for coronavirusAddressing a press briefing Niti Aayog member and head of the national task force on Covid19 VK Paul said PostCovid subacute morbidities are a new dimension Scientific and medical communities are keeping an eye on it These things are happening to an extent We will have to be aware that there may be some impact later tooMeanwhile Health Secretary Rajesh Bhushan called the coronavirus situation in the country reassuring with the daily infection rate as well as the fatality rate having shown a downward trend in the last five daysIn the context of pandemic this is a short time but we must be satisfied that the results are showing Both the parameters show a satisfactory situation but there is no reason for us to slacken our guard We must be alert he addedAlluding to vaccine development in the country they said that one of the three vaccine candidates would enter the third phase of the preclinical human trials by Wednesday However they did not reveal the names of the vaccineIndia has currently three vaccine candidates for Covid19 ChAdOx1 developed by Oxford University and manufactured jointly by the Serum Institute of India Pune and AstraZeneca Bharat Biotechs Covaxin jointly developed with the Indian Council of Medical Research and Zycov D by Zydus CadilaPaul refused to divulge the date of completion of vaccine development and issued a word of caution by asking people not to assume that any vaccine which is going for trial will be successfulThe announcement of status on the vaccine comes a day after the National Expert Group on Vaccine Administration met five domestic Covid vaccine manufacturers on Monday to review the clinical trial stages of these vaccine candidates The manufacturers included two whose products are not yet in the clinical trial stages in IndiaWe spoke to vaccine manufactures and requested them to provide more clear cut data information on their individual capacity and how they will pan out on time We asked them how they can ramp up the capacity This is a dialogue in motion India has huge potential and capacity Paul saidBesides this the Ministry of Health and Family Welfare divulged that India had exported 23 lakh PPE kits in July and 157 lakh in August to countries like the UK the US the United Arab Emirates Slovenia and SenegalIndias coronavirus tally crossed the 27 lakh mark on Tuesday with 55079 fresh cases in 24 hours while the toll climbed to 51797 with 876 more fatalities The recovered patients are 293 times the active onesOnly 25 per cent of the total cases are active Death rate stands at 192 per cent while the recovery rate is at 7318 percentNumber of Covid19 tests per day has gone up to nine lakh per day which is remarkable Testing is the key to disease containment and reducing mortality and improving outcomes Paul said cautioning people not to be lax as the challenge has not subsidedKeep scrolling to read more newsCatch up on all the latest Crime National International and Hatke news here Also download the new midday Android and iOS apps to get latest updates MidDay is now on Telegram Click here to join our channel middayinfomedialtd and stay updated with the latest newsThis story has been sourced from a third party syndicated feed agencies Midday accepts no responsibility or liability for its dependability trustworthiness reliability and data of the text Midday managementmiddaycom reserves the sole right to alter delete or remove without notice the content in its absolute discretion for any reason whatsoever